Filter
3036
Filtered Results: 3036
Text search:
antiretrovirals
Featured
Recommendations
234
New Publications
817
Language
Document type
No document type
2054
Studies & Reports
349
Guidelines
344
Manuals
88
Strategic & Response Plan
64
Fact sheets
51
Training Material
36
Infographics
27
Situation Updates
16
Brochures
3
Online Courses
2
App
1
Resource Platforms
1
Countries / Regions
South Africa
103
Kenya
94
India
83
Zambia
76
Tanzania
75
Malawi
74
Ethiopia
65
Global
60
Nigeria
57
Uganda
55
Rwanda
53
Western and Central Europe
53
Africa
49
Namibia
49
Nepal
47
Latin America and the Carribbean
47
Lesotho
42
Liberia
41
Zimbabwe
40
Ukraine
38
Eastern Europe
38
Myanmar / Burma
35
Venezuela
33
Mozambique
32
Ghana
31
Sierra Leone
30
Asia
26
Senegal
24
Indonesia
23
Botswana
21
Cambodia
20
Paraguay
20
Russia
20
Germany
17
Bangladesh
17
Burkina Faso
16
Argentina
16
Brazil
16
Philippines
15
Colombia
14
Congo, Democratic Republic of
14
South–East Asia Region
14
East and Southern Africa
13
Cameroon
12
Haiti
11
Eswatini/ Swaziland
11
El Salvador
10
Benin
9
Peru
9
Bolivia
9
West and Central Africa
8
Tajikistan
7
Albania
7
North Macedonia
6
Georgia
6
South Sudan
6
Pakistan
6
Syria
5
Middle East and North Africa
5
Guinea
4
Armenia
4
Eastern Europe and Central Asia
4
Moldova
4
Sudan
4
Angola
4
Ecuador
4
Thailand
3
Guinea-Bissau
3
Western Pacific Region
3
Southern Africa
3
Vietnam
3
Central African Republic
3
Somalia
3
Iran
2
Estonia
2
Afghanistan
2
Jordan
2
Yemen
2
Romania
2
Mali
2
Libya
2
Bhutan
2
Switzerland
1
Serbia
1
Gambia
1
China
1
Chile
1
Canada
1
Laos
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Italy
1
USA
1
Dominican Republic
1
Hungary
1
Saudi Arabia
1
North America
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Belgium
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Sri Lanka
1
Djibouti
1
Egypt
1
Palestine
1
Poland
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1282
Clinical Guidelines
231
Women & Child Health
136
Public Health
82
Capacity Building
62
Key Resources
55
Pharmacy & Technologies
24
Annual Report MEDBOX
1
Toolboxes
HIV
882
TB
389
COVID-19
103
Pharmacy
75
Caregiver
54
Mental Health
51
Refugee
35
Conflict
33
AMR
33
Health Financing Toolbox
29
Global Health Education
28
NTDs
27
Ebola & Marburg
24
Disability
20
NCDs
20
Natural Hazards
12
Rapid Response
10
Polio
10
Social Ethics
5
Planetary Health
3
Zika
2
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure...
Le taux de rétention est un indicateur essentiel du programme. C’est une occasion pour les différents acteurs d’évaluer les progrès réalisés dans le maintien en vie des adultes et des enfants infectés qui sont mis sous traitement antirétroviral pendant une période déterminée.
Journal of the International AIDS Society 2017, 20(Suppl 4):21644
National AIDS Programme in Myanmar has made significant progress in scaling up antiretroviral treatment (ART) services and recognizes the importance of differentiated care for people living with HIV. Indeed, long centred around t...
National AIDS Programme in Myanmar has made significant progress in scaling up antiretroviral treatment (ART) services and recognizes the importance of differentiated care for people living with HIV. Indeed, long centred around t...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
The USAID | DELIVER PROJECT, Task Order 4, developed this guide for quantifying health commodities; it will assist technical advisors, program managers, warehouse managers, procurement officers, and service providers in (1) estimating the total commodity needs and costs for successful implementation...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Global and Regional Data 1 December 2021; The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral therapy, and 90% of people on treatment were...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
Dans la plupart des pays, les services de lutte contre la tuberculose (TB) sont décentralisés jusqu’aux dispensaires
les plus périphériques et souvent au sein même des villages et des quartiers. Par contre, les services
de lutte contre le VIH/Sida sont généralement beaucoup plus centralis...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
Senegal has adopted the World Health Organization–Joint United Nations Programme on HIV/AIDS recommended 90-90-90 targets.5 The adoption of this strategy means that the country is expected, by 2020, to have 90% of its population living with HIV diagnosed, 90% of all those diagnosed receiving susta...
Barriers to HIV Services and Treatment for Persons with Disabilities in Zambia
The 80-page report documents the obstacles faced by people with disabilities in both the community and healthcare settings. These include pervasive stigma and discrimination, lack of access to inclusive HIV prevention ed...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
En 2016, l’ONUSIDA lançait un appel pour que les pays d’Afrique de l’Ouest et du Centre accélérent la riposte au sida. En effet, si dans des pays d’Afrique de l’Est et du Sud les avancées sont réelles, ceux de l’Afrique de l’Ouest et du Centre sont encore en retard dans l’accès...
FANTA provided technical support to Haiti’s Ministry of Public Health and Population for the development of national guidelines and an accompanying flipchart, which provide practical solutions to nutrition problems for people living with HIV, as well as guidance on nutritionally managing the sympt...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Advanced HIV disease (defined in persons living with HIV with a CD4 cell count of <200cells/mm3 or presenting with a WHO Stage 3/4 AIDS-defining illness) poses a challenge to many countries globally and is responsible for significant mortality and morbidity among people living with HIV. In 2017, WHO...
